Erasca, Inc. (ERAS)
14.14
-0.16
(-1.12%)
USD |
NASDAQ |
Oct 07, 16:00
14.14
0.00 (0.00%)
After-Hours: 20:00
Erasca Market Cap : 4.420B for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 4.470B |
| October 05, 2026 | 4.601B |
| October 02, 2026 | 4.607B |
| October 01, 2026 | 4.557B |
| September 30, 2026 | 4.582B |
| September 29, 2026 | 4.441B |
| September 28, 2026 | 4.416B |
| September 25, 2026 | 4.454B |
| September 24, 2026 | 4.538B |
| September 23, 2026 | 4.359B |
| September 22, 2026 | 4.860B |
| September 21, 2026 | 4.701B |
| September 18, 2026 | 4.616B |
| September 17, 2026 | 4.795B |
| September 16, 2026 | 4.801B |
| September 15, 2026 | 5.079B |
| September 14, 2026 | 5.051B |
| September 11, 2026 | 4.963B |
| September 10, 2026 | 5.010B |
| September 09, 2026 | 4.907B |
| September 08, 2026 | 5.088B |
| September 04, 2026 | 5.060B |
| September 03, 2026 | 5.082B |
| September 02, 2026 | 5.117B |
| September 01, 2026 | 5.238B |
| Date | Value |
|---|---|
| August 31, 2026 | 5.589B |
| August 28, 2026 | 5.635B |
| August 27, 2026 | 6.092B |
| August 26, 2026 | 5.985B |
| August 25, 2026 | 5.551B |
| August 24, 2026 | 5.501B |
| August 21, 2026 | 5.510B |
| August 20, 2026 | 5.338B |
| August 19, 2026 | 5.648B |
| August 18, 2026 | 5.657B |
| August 17, 2026 | 5.714B |
| August 14, 2026 | 5.745B |
| August 13, 2026 | 5.582B |
| August 12, 2026 | 5.807B |
| August 11, 2026 | 5.723B |
| August 10, 2026 | 5.664B |
| August 07, 2026 | 5.754B |
| August 06, 2026 | 5.710B |
| August 05, 2026 | 5.787B |
| August 04, 2026 | 5.713B |
| August 03, 2026 | 5.545B |
| July 31, 2026 | 5.641B |
| July 30, 2026 | 5.806B |
| July 29, 2026 | 5.507B |
| July 28, 2026 | 5.644B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.677B |
| Twist Bioscience Corp. | 9.749B |
| Immunome, Inc. | 2.164B |
| Oncolytics Biotech, Inc. | 74.16M |
| Sangamo Therapeutics, Inc. | 58.00M |
Market Cap Related Metrics
| PEG Ratio | -0.1339 |
| Price to Book Value | 12.21 |
| Price | 14.14 |
| Earnings Yield | -6.75% |
| PEGY Ratio | -0.1339 |